Izumi N - Search Results

1

Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.

Kaneko S, Kurosaki M, Mashiba T, Marusawa H, Kondo M, Kojima Y, Uchida Y, Fujii H, Akahane T, Yagisawa H, Kusakabe A, Kobashi H, Abe T, Yoshida H, Ogawa C, Furuta K, Tamaki N, Tsuji K, Matsushita T, Izumi N; Japanese Red Cross Liver Study Group. Kaneko S, et al. Among authors: izumi n. J Med Virol. 2023 Jan;95(1):e28210. doi: 10.1002/jmv.28210. Epub 2022 Oct 20. J Med Virol. 2023. PMID: 36222204

2

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.

Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C. Koizumi K, et al. Among authors: izumi n. Hepatology. 1995 Jul;22(1):30-5. Hepatology. 1995. PMID: 7541387

3

Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues.

Kurosaki M, Enomoto N, Sakamoto N, Tanaka Y, Tang L, Hoshino Y, Izumi N, Marumo F, Sato C. Kurosaki M, et al. Among authors: izumi n. J Hepatol. 1995 May;22(5):527-35. doi: 10.1016/0168-8278(95)80446-3. J Hepatol. 1995. PMID: 7650332

4

Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis.

Asahina Y, Enomoto N, Ogura Y, Sakuma I, Kurosaki M, Izumi N, Marumo F, Sato C. Asahina Y, et al. Among authors: izumi n. J Med Virol. 1996 Feb;48(2):171-8. doi: 10.1002/(SICI)1096-9071(199602)48:2<171::AID-JMV9>3.0.CO;2-6. J Med Virol. 1996. PMID: 8835351

5

Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.

Kurosaki M, Enomoto N, Asahina Y, Sakuma I, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. Kurosaki M, et al. Among authors: izumi n. J Med Virol. 1996 Jun;49(2):115-23. doi: 10.1002/(SICI)1096-9071(199606)49:2<115::AID-JMV8>3.0.CO;2-8. J Med Virol. 1996. PMID: 8991934

6

Differential effect of interferon on hepatitis C virus 1b quasispecies in the nonstructural protein 5A gene.

Sakuma I, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Sakuma I, et al. Among authors: izumi n. J Infect Dis. 1999 Oct;180(4):1001-9. doi: 10.1086/315000. J Infect Dis. 1999. PMID: 10479124

7

Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection.

Murakami T, Enomoto N, Kurosaki M, Izumi N, Marumo F, Sato C. Murakami T, et al. Among authors: izumi n. Hepatology. 1999 Oct;30(4):1045-53. doi: 10.1002/hep.510300405. Hepatology. 1999. PMID: 10498658

8

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

Nagayama K, Kurosaki M, Enomoto N, Maekawa SY, Miyasaka Y, Tazawa J, Izumi N, Marumo F, Sato C. Nagayama K, et al. Among authors: izumi n. Virology. 1999 Oct 10;263(1):244-53. doi: 10.1006/viro.1999.9924. Virology. 1999. PMID: 10544098 Free article.

9

CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.

Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C. Itakura J, et al. Among authors: izumi n. J Med Virol. 2001 Jan;63(1):22-8. J Med Virol. 2001. PMID: 11130883

10

Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization.

Nagayama K, Enomoto N, Miyasaka Y, Kurosaki M, Chen CH, Sakamoto N, Nakagawa M, Sato C, Tazawa J, Ikeda T, Izumi N, Watanabe M. Nagayama K, et al. Among authors: izumi n. Am J Gastroenterol. 2001 Jul;96(7):2211-7. doi: 10.1111/j.1572-0241.2001.03959.x. Am J Gastroenterol. 2001. PMID: 11467655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

848 results

Search Page